iRhythm Technologies, Inc.(IRTC) Stock Research - Grey Stern Research
Loading...

iRhythm Technologies, Inc. (IRTC) Stock Analysis

$105.29 (-0.66%)

IRTC Financial Performance


Use the table below to view iRhythm Technologies, Inc.'s financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q4 - 2024

Metric Value Ranking among Peers
Price $105.99 -
52 Week Low $55.92 -
52 Week High $128.52 -
Market Cap $3.4 Billion 4/14
Gross Margin 70% 7/14
Profit Margin -1% 6/14
EBITDA margin -2% 7/14
Q4 - 2024 Revenue $164.3 Million 7/14
Q4 - 2024 Earnings -$1.3 Million 6/14
Q4 - 2024 Free Cash Flow $12.4 Million 4/14
Trailing 4 Quarters Revenue $591.8 Million 7/14
Trailing 4 Quarters Earnings -$113.3 Million 12/14
Quarterly Earnings Growth 97% 3/14
Annual Earnings Growth 6% 5/14
Quarterly Revenue Growth 24% 3/14
Annual Revenue Growth 17% 4/14
Cash On Hand $419.6 Million 2/14
Short Term Debt $15.9 Million 5/14
Long Term Debt $721.0 Million 4/14

iRhythm Technologies, Inc. Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare iRhythm Technologies, Inc.'s metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE -1.00 6/14
PS 5.72 2/14
PB 37.22 2/14
PC 8.06 11/14
Liabilities to Equity 9.25 2/14
ROA -0.12 9/14
ROE -1.25 13/14
Current Ratio 1.11 13/14
Quick Ratio 0.64 4/14
Long Term Debt to Equity 7.93 2/14
Debt to Equity 8.11 2/14
Burn Rate 12.29 1/14
Cash to Cap 0.12 4/14
CCR -9.29 12/14
EV to EBITDA -906.33 14/14
EV to Revenue 6.25 2/14

Company Details

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

CEO: Mr. Kevin King

Website: https://www.irhythmtech.com

Address: 650 Townsend St Ste 500 San Francisco, CALIFORNIA

Exchange: NASDAQ Global Select

Industry: Medical Devices

iRhythm Technologies, Inc. Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to iRhythm Technologies, Inc.. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
Glaukos Corporation GKOS $5.5 Billion
LivaNova PLC LIVN $2.0 Billion
Bruker Corporation BRKR $5.9 Billion
NuVasive, Inc. NUVA $2.1 Billion
Integer Holdings Corporation ITGR $4.3 Billion
CONMED Corporation CNMD $1.6 Billion
Heska Corporation HSKA $1.3 Billion
Surmodics, Inc. SRDX $421.2 Million
Orthofix Medical Inc. OFIX $553.7 Million
OrthoPediatrics Corp. KIDS $534.9 Million
NeuroPace, Inc. NPCE $362.9 Million
Sight Sciences, Inc. SGHT $165.3 Million
Paragon 28, Inc. FNA $1.1 Billion
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
IRTC Income Statements
Quarter Year Revenue Earnings
Q4 2024 $ 164.3 Million -$1.3 Million
Q3 2024 $ 147.5 Million -$46.2 Million
Q2 2024 $ 148.0 Million -$20.1 Million
Q1 2024 $ 131.9 Million -$45.7 Million
Q4 2023 $ 132.5 Million -$38.7 Million
Q3 2023 $ 124.6 Million -$27.1 Million
Q2 2023 $ 124.1 Million -$18.5 Million
Q1 2023 $ 111.4 Million -$39.1 Million

View All

IRTC Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q4 2024 $419.6 Million $931.4 Million $736.9 Million $90.9 Million
Q3 2024 $519.5 Million $909.7 Million $735.4 Million $71.8 Million
Q2 2024 $550.6 Million $919.2 Million $736.5 Million $99.2 Million
Q1 2024 $520.4 Million $909.8 Million $737.0 Million $90.3 Million
Q4 2023 $36.2 Million $433.1 Million $129.8 Million $210.1 Million
Q3 2023 $47.5 Million $439.8 Million $131.7 Million $219.8 Million
Q2 2023 $61.6 Million $429.5 Million $129.3 Million $223.9 Million
Q1 2023 $52.8 Million $421.7 Million $131.0 Million $221.8 Million

View All

IRTC Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q4 2024 $12.4 Million -$6.8 Million -$99.9 Million
Q3 2024 $15.5 Million -$8.8 Million -$22.7 Million
Q2 2024 $3.4 Million -$8.5 Million $30.1 Million
Q1 2024 -$61.8 Million -$9.8 Million $484.2 Million
Q4 2023 $10.9 Million $26.9 Million -$1.8 Million
Q3 2023 -$2.0 Million $0 -$2.0 Million
Q2 2023 -$14.0 Million -$9.4 Million $8.8 Million
Q1 2023 -$39.2 Million -$8.4 Million -$26.0 Million

View All